2
|
Mousseau JJ, Perry MA, Bundesmann MW, Chinigo GM, Choi C, Gallego G, Hicklin RW, Hoy S, Limburg DC, Sach NW, Zhang Y. Automated Nanomole-Scale Reaction Screening toward Benzoate Bioisosteres: A Photocatalyzed Approach to Highly Elaborated Bicyclo[1.1.1]Pentanes. ACS Catal 2021. [DOI: 10.1021/acscatal.1c05076] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Affiliation(s)
- James J. Mousseau
- Pfizer Medicine Design, 445 Eastern Point Rd, Groton, Connecticut 06340, United States
| | - Matthew A. Perry
- Pfizer Medicine Design, 445 Eastern Point Rd, Groton, Connecticut 06340, United States
| | - Mark W. Bundesmann
- Pfizer Medicine Design, 445 Eastern Point Rd, Groton, Connecticut 06340, United States
| | - Gary M. Chinigo
- Pfizer Medicine Design, 445 Eastern Point Rd, Groton, Connecticut 06340, United States
| | - Chulho Choi
- Pfizer Medicine Design, 445 Eastern Point Rd, Groton, Connecticut 06340, United States
| | - Gary Gallego
- Pfizer La Jolla Laboratories, 10770 Science Center Drive, San Diego, California 92121, United States
| | - Robert W. Hicklin
- Pfizer Medicine Design, 445 Eastern Point Rd, Groton, Connecticut 06340, United States
| | - Susan Hoy
- Pfizer Medicine Design, 445 Eastern Point Rd, Groton, Connecticut 06340, United States
| | - David C. Limburg
- Pfizer Medicine Design, 445 Eastern Point Rd, Groton, Connecticut 06340, United States
| | - Neal W. Sach
- Pfizer La Jolla Laboratories, 10770 Science Center Drive, San Diego, California 92121, United States
| | - Yuan Zhang
- Pfizer Medicine Design, 610 Main St., Cambridge, Massachusetts 02139, United States
| |
Collapse
|
4
|
Fensome A, Ambler CM, Arnold E, Banker ME, Brown MF, Chrencik J, Clark JD, Dowty ME, Efremov IV, Flick A, Gerstenberger BS, Gopalsamy A, Hayward MM, Hegen M, Hollingshead BD, Jussif J, Knafels JD, Limburg DC, Lin D, Lin TH, Pierce BS, Saiah E, Sharma R, Symanowicz PT, Telliez JB, Trujillo JI, Vajdos FF, Vincent F, Wan ZK, Xing L, Yang X, Yang X, Zhang L. Dual Inhibition of TYK2 and JAK1 for the Treatment of Autoimmune Diseases: Discovery of (( S)-2,2-Difluorocyclopropyl)((1 R,5 S)-3-(2-((1-methyl-1 H-pyrazol-4-yl)amino)pyrimidin-4-yl)-3,8-diazabicyclo[3.2.1]octan-8-yl)methanone (PF-06700841). J Med Chem 2018; 61:8597-8612. [PMID: 30113844 DOI: 10.1021/acs.jmedchem.8b00917] [Citation(s) in RCA: 97] [Impact Index Per Article: 16.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Abstract
Cytokine signaling is an important characteristic of autoimmune diseases. Many pro-inflammatory cytokines signal through the Janus kinase (JAK)/Signal transducer and activator of transcription (STAT) pathway. JAK1 is important for the γ-common chain cytokines, interleukin (IL)-6, and type-I interferon (IFN) family, while TYK2 in addition to type-I IFN signaling also plays a role in IL-23 and IL-12 signaling. Intervention with monoclonal antibodies (mAbs) or JAK1 inhibitors has demonstrated efficacy in Phase III psoriasis, psoriatic arthritis, inflammatory bowel disease, and rheumatoid arthritis studies, leading to multiple drug approvals. We hypothesized that a dual JAK1/TYK2 inhibitor will provide additional efficacy, while managing risk by optimizing selectivity against JAK2 driven hematopoietic changes. Our program began with a conformationally constrained piperazinyl-pyrimidine Type 1 ATP site inhibitor, subsequent work led to the discovery of PF-06700841 (compound 23), which is in Phase II clinical development (NCT02969018, NCT02958865, NCT03395184, and NCT02974868).
Collapse
Affiliation(s)
- Andrew Fensome
- Medicine Design, Pfizer Inc., 1 Portland Street , Cambridge , Massachusetts 02139 , United States
| | - Catherine M Ambler
- Medicine Design, Pfizer Inc., Eastern Point Road , Groton , Connecticut 06340 , United States
| | - Eric Arnold
- Medicine Design, Pfizer Inc., Eastern Point Road , Groton , Connecticut 06340 , United States
| | - Mary Ellen Banker
- Medicine Design, Pfizer Inc., Eastern Point Road , Groton , Connecticut 06340 , United States
| | - Matthew F Brown
- Medicine Design, Pfizer Inc., Eastern Point Road , Groton , Connecticut 06340 , United States
| | - Jill Chrencik
- Medicine Design, Pfizer Inc., Eastern Point Road , Groton , Connecticut 06340 , United States
| | - James D Clark
- Inflammation and Immunology, Pfizer Inc., 1 Portland Street , Cambridge , Massachusetts 02139 , United States
| | - Martin E Dowty
- Medicine Design, Pfizer Inc., 1 Portland Street , Cambridge , Massachusetts 02139 , United States
| | - Ivan V Efremov
- Medicine Design, Pfizer Inc., 1 Portland Street , Cambridge , Massachusetts 02139 , United States
| | - Andrew Flick
- Medicine Design, Pfizer Inc., Eastern Point Road , Groton , Connecticut 06340 , United States
| | - Brian S Gerstenberger
- Medicine Design, Pfizer Inc., 1 Portland Street , Cambridge , Massachusetts 02139 , United States
| | - Ariamala Gopalsamy
- Medicine Design, Pfizer Inc., 1 Portland Street , Cambridge , Massachusetts 02139 , United States
| | - Matthew M Hayward
- Medicine Design, Pfizer Inc., Eastern Point Road , Groton , Connecticut 06340 , United States
| | - Martin Hegen
- Inflammation and Immunology, Pfizer Inc., 1 Portland Street , Cambridge , Massachusetts 02139 , United States
| | - Brett D Hollingshead
- Drug Safety Research and Development, Pfizer Inc., 1 Portland Street , Cambridge , Massachusetts 02139 , United States
| | - Jason Jussif
- Inflammation and Immunology, Pfizer Inc., 1 Portland Street , Cambridge , Massachusetts 02139 , United States
| | - John D Knafels
- Medicine Design, Pfizer Inc., Eastern Point Road , Groton , Connecticut 06340 , United States
| | - David C Limburg
- Medicine Design, Pfizer Inc., Eastern Point Road , Groton , Connecticut 06340 , United States
| | - David Lin
- Medicine Design, Pfizer Inc., Eastern Point Road , Groton , Connecticut 06340 , United States
| | - Tsung H Lin
- Inflammation and Immunology, Pfizer Inc., 1 Portland Street , Cambridge , Massachusetts 02139 , United States
| | - Betsy S Pierce
- Medicine Design, Pfizer Inc., Eastern Point Road , Groton , Connecticut 06340 , United States
| | - Eddine Saiah
- Medicine Design, Pfizer Inc., 1 Portland Street , Cambridge , Massachusetts 02139 , United States
| | - Raman Sharma
- Medicine Design, Pfizer Inc., Eastern Point Road , Groton , Connecticut 06340 , United States
| | - Peter T Symanowicz
- Inflammation and Immunology, Pfizer Inc., 1 Portland Street , Cambridge , Massachusetts 02139 , United States
| | - Jean-Baptiste Telliez
- Inflammation and Immunology, Pfizer Inc., 1 Portland Street , Cambridge , Massachusetts 02139 , United States
| | - John I Trujillo
- Medicine Design, Pfizer Inc., Eastern Point Road , Groton , Connecticut 06340 , United States
| | - Felix F Vajdos
- Medicine Design, Pfizer Inc., Eastern Point Road , Groton , Connecticut 06340 , United States
| | - Fabien Vincent
- Medicine Design, Pfizer Inc., Eastern Point Road , Groton , Connecticut 06340 , United States
| | - Zhao-Kui Wan
- Medicine Design, Pfizer Inc., 1 Portland Street , Cambridge , Massachusetts 02139 , United States
| | - Li Xing
- Medicine Design, Pfizer Inc., 1 Portland Street , Cambridge , Massachusetts 02139 , United States
| | - Xiaojing Yang
- Medicine Design, Pfizer Inc., 1 Portland Street , Cambridge , Massachusetts 02139 , United States
| | - Xin Yang
- Medicine Design, Pfizer Inc., Eastern Point Road , Groton , Connecticut 06340 , United States
| | - Liying Zhang
- Medicine Design, Pfizer Inc., 1 Portland Street , Cambridge , Massachusetts 02139 , United States
| |
Collapse
|
7
|
Zapf CW, Gerstenberger BS, Xing L, Limburg DC, Anderson DR, Caspers N, Han S, Aulabaugh A, Kurumbail R, Shakya S, Li X, Spaulding V, Czerwinski RM, Seth N, Medley QG. Covalent Inhibitors of Interleukin-2 Inducible T Cell Kinase (Itk) with Nanomolar Potency in a Whole-Blood Assay. J Med Chem 2012; 55:10047-63. [DOI: 10.1021/jm301190s] [Citation(s) in RCA: 58] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
Affiliation(s)
- Christoph W. Zapf
- BioTherapeutics Chemistry, Pfizer Worldwide Medicinal Chemistry, 200 Cambridgepark Drive, Cambridge, Massachusetts
02140, United States
| | - Brian S. Gerstenberger
- BioTherapeutics
Chemistry, Pfizer Worldwide Medicinal Chemistry, Eastern Point Road, Groton, Connecticut 06340, United States
| | - Li Xing
- BioTherapeutics Chemistry, Pfizer Worldwide Medicinal Chemistry, 200 Cambridgepark Drive, Cambridge, Massachusetts
02140, United States
| | - David C. Limburg
- BioTherapeutics
Chemistry, Pfizer Worldwide Medicinal Chemistry, Eastern Point Road, Groton, Connecticut 06340, United States
| | - David R. Anderson
- BioTherapeutics
Chemistry, Pfizer Worldwide Medicinal Chemistry, Eastern Point Road, Groton, Connecticut 06340, United States
| | - Nicole Caspers
- Structure Biology and Biophysics, Pfizer Worldwide Medicinal Chemistry, Eastern Point
Road, Groton, Connecticut 06340, United States
| | - Seungil Han
- Structure Biology and Biophysics, Pfizer Worldwide Medicinal Chemistry, Eastern Point
Road, Groton, Connecticut 06340, United States
| | - Ann Aulabaugh
- Structure Biology and Biophysics, Pfizer Worldwide Medicinal Chemistry, Eastern Point
Road, Groton, Connecticut 06340, United States
| | - Ravi Kurumbail
- Structure Biology and Biophysics, Pfizer Worldwide Medicinal Chemistry, Eastern Point
Road, Groton, Connecticut 06340, United States
| | - Subarna Shakya
- Inflammation and Autoimmunity, Pfizer Research, 200 Cambridgepark Drive, Cambridge,
Massachusetts 02140, United States
| | - Xin Li
- Inflammation and Autoimmunity, Pfizer Research, 200 Cambridgepark Drive, Cambridge,
Massachusetts 02140, United States
| | - Vikki Spaulding
- Inflammation and Autoimmunity, Pfizer Research, 200 Cambridgepark Drive, Cambridge,
Massachusetts 02140, United States
| | - Robert M. Czerwinski
- Inflammation and Autoimmunity, Pfizer Research, 200 Cambridgepark Drive, Cambridge,
Massachusetts 02140, United States
| | - Nilufer Seth
- Inflammation and Autoimmunity, Pfizer Research, 200 Cambridgepark Drive, Cambridge,
Massachusetts 02140, United States
| | - Quintus G. Medley
- Inflammation and Autoimmunity, Pfizer Research, 200 Cambridgepark Drive, Cambridge,
Massachusetts 02140, United States
| |
Collapse
|